Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results

Supportive Care in Cancer

Volumn 21, Issue 11, 2013, Pages 3153-3158

  Garzón Rodríguez, Cristina ^a   Casals Merchan, Miquel ^a   Calsina Berna, Agnes ^a   López Rómboli, Eugenia ^a   Porta Sales, Josep ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Cancer; Lidocaine 5 patch; Neuropathic pain; Painful scar

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; DULOXETINE; GABAPENTIN; LIDOCAINE; MORPHINE; NARCOTIC ANALGESIC AGENT; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; LUNG CARCINOMA; MALE; MASTECTOMY; NEUROPATHIC PAIN; OPEN STUDY; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCAR; SYSTEMIC DISEASE; THORACOTOMY; TRANSDERMAL PATCH;

ANESTHETICS, LOCAL; BREAST NEOPLASMS; CICATRIX; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIDOCAINE; MALE; MASTECTOMY; MIDDLE AGED; NEURALGIA; PALLIATIVE CARE; PILOT PROJECTS; PROSPECTIVE STUDIES; THORACIC NEOPLASMS; THORACOTOMY; TRANSDERMAL PATCH;

EID: 84885602197     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1948-7     Document Type: Article

References (21)

1. Garcia de Paredes ML, Moral González F, Martínez del Prado P, Martí Ciriquian JL, Enrech Francés S, Cobo Dols M et al (2011) First evidence of oncologic neuropathic pain prevalence alter screening 8615 cancer patients. Results of the On study. Ann Oncol 22:924-930
2. Faisinger R, Nekolaichuk C, Lawlor P, Neumann C, Hanson J, Vigano A (2005) A multicenter study of the revised edmonton staging system for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29(3):224-236
3. Caraceni A, Portenoy R (1999) An international survey of cancer pain characteristics and syndromes. Pain 82:263-274
4. Vadauloca A, Raptis E et al (2012) Pharmacological treatment on neuropathic cancer pain: a comprehensive review of the current literature. Pain Pract 12(3):219-251
5. Stute P, Soukup J, Menzel M et al (2003) Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage 26:1123-1131
6. Muguruza I, Aranda JL, García-Yuste M (2011) Tratamiento del cáncer de pulmón con invasión de la pared torácica. Arch Bronconeumol 47:27-32
7. Stoeben E, Ludwig C (2009) Chest wall resection for lung cancer: indications and techniques. Eur J Cardiothoracic Surg 35:450-456
8. Rogers ML, Duffy JP (2000) Surgical aspects of chronic post-thoracotomy pain. Eur J Cardiothorac Surg 18:711-716
9. Kehlet H, Jensen TS, Woolf C (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618-1625
10. Pertunnen K, Tasmuth T, Kalso E (1999) Chronic pain after thoracic surgery: a follow up study. Acta Anaesthesiol Scand 43:563-567
11. Macdonald L, Bruce J, Scott NW, Smith WCS, Chambers WA (2005) Long-term follow up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225-230
12. Dworkin R, O'Connor A, Audette J, Baron R, Gourlay GK, Haanpää ML et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85:S3-S14
13. Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M et al (2003) Efficacy of lidocaine patch 5 % in the treatment of focal peripheral neurophatic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 106:151-158
14. Galer BS, Rowbotham MC, Perander J, Friedman E (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enrichment enrollment study. Pain 80:533-538
15. Rowbotham MC, Davies PS, Verkempinck C, Galer BS (1996) Lidocaine patch: double-blind, controlled study of a new treatment for post-herpetic neuralgia. Pain 65:39-44
16. Fleming JA, O'Connor BD (2009) Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. Pain Res Manage 14:381-388
17. Cheville A, Sloan J, Northfelt D, Jillella A, Wong G, Bearden J et al (2009) Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Canc 17:451-460
18. Freynhagen R, Baron R, Gockel V, Tölle TR (2006) PainDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22:1911-1920
19. Krumova E, Zeller M, Westermann A, Maier C (2012) Lidocaine patch (5 %) produces a selective, but incomplete block of Adelta and C fibers. Pain 153:273-280
20. Hans G, Joukes E, Verhulst J, Vercauteren M (2009) Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5 % patches: study of 40 consecutive cases. Curr Med Res Opin 25:2737-2743
21. Gammaitoni AR, Davis MW (2002) Pharmacokinetics and tolerability of lidocaine patch 5 % with extended doping. Ann Pharmacother 36:236-240